Retinoic acid blocks adipogenesis by inhibiting C/EBPβ-mediated transcription

Molecular and Cellular Biology

Volumn 17, Issue 3, 1997, Pages 1552-1561

  Schwarz, Emily J ^a   Reginato, Mauricio J ^a   Shao, Dalei ^a   Krakow, Samuel L ^a   Lazar, Mitchell A ^a,b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; PEROXISOME PROLIFERATOR; RECEPTOR; RETINOIC ACID; RETINOIC ACID RECEPTOR; TRANSCRIPTION FACTOR;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL STRAIN 3T3; GENE EXPRESSION; GENE INDUCTION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; IMMUNOBLOTTING; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL;

ANIMALIA;

EID: 0031037988     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.17.3.1552     Document Type: Article

References (73)

1. Akira, S., H. Isshiki, T. Sugita, O. Tanabe, S. Kinoshita, Y. Nishio, T. Nakajima, T. Hirano, and T. Kishimoto. 1990. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 9:1897-1906.
2. Ausubel, F. M., R. Brent, R. Kingston, D. D. Moore, J. A. Smith, J. G. Seidman, and K. Struhl (ed.). 1987. Current protocols in molecular biology. Greene Publishing-Wiley Interscience, New York, N.Y.
3. Avitahl, N., and K. Calame. 1994. The C/EBP family of proteins distorts DNA upon binding but does not introduce a large directed bend. J. Biol. Chem. 269:23553-23562.
4. Brent, G. A., J. W. Harney, Y. Chen, R. L. Warne, D. D. Moore, and P. R. Larsen. 1989. Mutations of the rat growth hormone promoter which increase and decrease response to thyroid hormone define a consensus thyroid hormone response element. Mol. Endocrinol. 3:1996-2004.
5. Bugge, T. H., J. Pohl, O. Lonnoy, and H. G. Stunnenberg. 1992. RXRα, a promiscuous partner of retinoic acid and thyroid hormone receptors. EMBO J. 11:1409-1418.
6. Caldenhoven, E., J. Liden, S. Wissink, A. Van de Stolpe, J. Raaijmakers, L. Koenderman, S. Okre, J. A. Gustafsson, and P. T. Van der Saag. 1995. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol. Endocrinol. 9:401-412.
7. Cao, Z., R. M. Umek, and S. L. McKnight. 1991. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 5:1538-1552.
8. Cavailles, V., S. Dauvois, F. L'Horset, G. Lopez, S. Hoare, P. J. Kushner, and M. G. Parker. 1995. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14:3741-3751.
9. Chakravarti, D., V. J. LaMorte, N. C. Nelson, T. Nakajima, I. G. Schulman, H. Juguilon, M. Montminy, and R. M. Evans. 1996. Role of CBP/p300 in nuclear receptor signaling. Nature 383:99-103.
10. Chawla, A., and M. A. Lazar. 1993. Induction of Rev-ErbAα, an orphan nuclear receptor encoded on the opposite strand of the α-thyroid hormone receptor gene, during adipocyte differentiation. J. Biol. Chem. 268:16265-16269.
11. Chawla, A., and M. A. Lazar. 1994. Peroxisome proliferator and retinoid signalling pathways coregulate preadipocyte phenotype and survival. Proc. Natl. Acad. Sci. USA 91:1786-1790.
12. Chawla, A., E. J. Schwarz, D. D. Dimaculangan, and M. A. Lazar. 1994. Peroxisome proliferator-activated receptor γ (PPARγ): adipose predominant expression and induction early in adipocyte differentiation. Endocrinology 135:798-800.
13. Chen, J. D., and R. M. Evans. 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457.
14. Christy, R. J., K. H. Faestner, D. E. Geiman, and M. D. Lane. 1991. CCAAT/enhancer binding protein gene promoter: binding of nuclear factors during differentiation of 3T3-L1 preadipocytes. Proc. Natl. Acad. Sci. USA 88:2593-2597.
15. Christy, R. J., V. W. Yang, J. M. Ntambi, D. E. Geiman, W. H. Landschulz, A. D. Friedman, Y. Nakabeppu, T. J. Kelly, and M. D. Lane. 1989. Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes. Genes Dev. 3:1323-1335.
16. Damm, K., R. A. Heyman, K. Umesono, and R. M. Evans. 1993. Functional inhibition of retinoic acid response by dominant negative retinoic acid receptor mutants. Proc. Natl. Acad. Sci. USA 90:2989-2993.
17. Danielian, P. S., R. White, J. A. Lees, and M. G. Parker. 1992. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J. 11:1025-1033.
18. Davis, K. D., T. J. Berrodin, J. E. Stelmach, J. D. Winkler, and M. A. Lazar. 1994. Endogenous RXRs can function as hormone receptors in pituitary cells. Mol. Cell. Biol. 14:7105-7110.
19. Descombes, P., and U. Schibler. 1991. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67:569-579.
20. Dimaculangan, D. D., A. Chawla, A. Boak, H. M. Kagan, and M. A. Lazar. 1994. Retinoic acid prevents down-regulation of ras recision gene/lysyl oxidase, an early event in adipose conversion. Differentiation 58:47-52.
21. Durand, B., M. Saunders, C. Gaudon, B. Roy, R. Losson, and P. Chambon. 1994. Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presencer of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J. 13:5370-5382.
22. Forman, B. M., P. Tontonoz, J. Chen, R. P. Brun, B. M. Spiegelman, and R. M. Evans. 1995. 15-Deoxy, delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell 83:803-812.
23. Freytag, S. O., D. L. Paielli, and J. D. Gilbert. 1994. Ectopic expression of the CCAAT/enhancer binding protein a promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes Dev. 8:1654-1663.
24. Halachmi, S., E. Marden, G. Martin, H. MacKay, C. Abbondanza, and M. Brown. 1994. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264:1455-1458.
25. Hanstein, B., R. Eckner, J. DiRenzo, S. Halachmi, H. Liu, B. Searcy, R. Kurokawa, and M. Brown. 1996. P300 is a component of an estrogen receptor coactivator complex. Proc. Natl. Acad. Sci. USA 93:11540-11545.
26. Imakado, S., J. R. Bickenbach, D. S. Bundman, J. A. Rothnagel, P. S. Attar, X.-J. Wang, V. R. Walczak, S. Wisniewski, J. Pote, J. S. Gordon, R. A. Heyman, R. M. Evans, and D. R. Roop. 1995. Targeting expression of a dominant negative retinoic acid receptor mutant in the epidermis of transgenic mice results in loss of barrier function. Genes Dev. 9:317-329.
27. Janknecht, R., and T. Hunter. 1996. A growing coactivator network. Nature 383:22-23.
28. Kamei, Y., T. Kawada, R. Kazuki, and E. Sugimoto. 1993. Retinoic acid receptor γ2 gene expression is up-regulated by retinoic acid in 3T3-L1 preadipocytes. Biochem. J. 293:807-812.
29. Kamei, Y., L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Gloss, S.-C. Lin, R. A. Heyman, D. W. Rose, C. K. Glass, and M. G. Rosenfeld. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414.
30. Kato, G. J., J. Barrett, M. Villa-Garcia, and C. V. Dang. 1990. An amino-terminal c-myc domain required for neoplastic transformation activates transcription. Mol. Cell. Biol. 10:5914-5920.
31. Kletzien, R. F., S. D. Clarke, and R. G. Ulrich. 1992. Enhancement of adipocyte differentiation by an insulin-sensitizing agent. Mol. Pharmacol. 41:393-398.
32. Kliewer, S. A., J. M. Lenhard, T. M. Willson, I. Patel, D. C. Morris, and J. M. Lehmann. 1995. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 83:813-819.
33. Kliewer, S. A., K. Umesono, D. J. Mangelsdorf, and R. M. Evans. 1992. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone, and vitamin D3 signalling. Nature 355:446-449.
34. Kliewer, S. A., K. Umesono, D. J. Noonan, R. A. Heyman, and R. M. Evans. 1992. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358:771-774.
35. Kuri-Harcuch, W. 1982. Differentiation of 3T3-F442A cells into adipocytes is inhibited by retinoic acid. Differentiation 23:164-169.
36. Kurokawa, R., J. DiRenzo, M. Boehm, J. Sugarman, B. Gloss, M. G. Rosenfeld, R. A. Heyman, and C. K. Glass. 1994. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature 371:528-531.
37. LeDouarin, B., C. Zechel, J.-M. Gamier, Y. Lutz, L. Tora, B. Pierrat, D. Heery, H. Gronemeyer, P. Chambon, and R. Losson. 1995. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J. 14:2020-2033.
38. Lee, J. W., F. Ryan, J. C. Swaffield, S. A. Johnston, and D. D. Moore. 1995. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature 374:91-94.
39. Lehmann, J. M., L. B. Moore, T. A. Smith-Oliver, W. O. Wilkison, T. M. Willson, and S. A. Kliewer. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for the nuclear peroxisome proliferator-activated receptor g (PPARγ). J. Biol. Chem. 270:12953-12956.
40. Lehmann, J. M., X. K. Zhang, and M. Pfahl. 1992. RAR gamma 2 expression is regulated through a retinoic acid response element embedded in Sp1 sites. Mol. Cell. Biol. 12:2976-2985.
41. Lillie, J. E., and M. R. Green. 1989. Transcription activation by the adeno-virus E1a protein. Nature 338:39-44.
42. Lin, F.-T., and M. D. Lane. 1992. Antisense CCAAT/enhancer-binding protein RNA suppresses coordinate gene expression and triglyceride accumulation during differentiation of 3T3-L1 preadipocytes. Genes Dev. 6:533-544.
43. Lin, F.-T., and M. D. Lane. 1994. CCAAT/cnhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc. Natl. Acad. Sci. USA 91:8757-8761.
44. Lin, F. T., O. A. MacDougald, A. M. Diehl, and M. D. Lane. 1993. A 30-kDa alternative translation product of the CCAAT/enhancer binding protein alpha message: transcriptional activator lacking antimitotic activity. Proc. Natl. Acad. Sci. USA 90:9606-9610.
45. MacDougald, O. A., and M. D. Lane. 1995. Transcriptional regulation of gene expression during adipocyte differentiation. Annu. Rev. Biochem. 64: 345-373.
46. Miller, A. D., and G. J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980-990.
47. Nerlov, C., and E. B. Ziff. 1994. Three levels of functional interaction determine the activity of CCAAT/enhancer binding protein-alpha on the serum albumin promoter. Genes Dev. 8:350-362.
48. Nerlov, C., and E. B. Ziff. 1995. CCAAT/enhancer binding protein-alpha amino acid motifs with dual TBP and TFIIB binding ability co-operate to activate transcription in both yeast and mammalian cells. EMBO J. 14:4318-4328.
49. Onate, S. A., S. Y. Tsai, M.-J. Tsai, and B. W. O'Malley. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor super-family. Science 270:1354-1357.
50. Osada, S., H. Yamamoto, T. Nishahara, and M. Imagawa. 1996. DNA binding specificity of the CCAAT/enhancer binding protein transcription factor family. J. Biol. Chem. 271:3891-3896.
51. Ossipow, V., P. Descombes, and U. Schibler. 1993. CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proc. Natl. Acad. Sci. USA 90:8219-8223.
52. Pfahl, M. 1993. Nuclear receptor/AP-1 interaction. Endocrine Rev. 14:651-658.
53. Pizzorno, M. C., M.-A. Mullen, Y.-N. Chang, and G. S. Hayward. 1991. The functionally active IE2 immediate-early regulatory protein of human cytomegalovirus is an 80-kilodalton polypeptide that contains two distinct activator domains and a duplicated nuclear localization signal. J. Virol. 65:3839-3852.
54. Ray, A., and K. E. Prefontaine. 1994. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA 91:752-756.
55. Saatcioglu, F., F. X. Claret, and M. Karin. 1995. Negative transcriptional regulation by nuclear receptors. Semin. Cancer Biol. 5:347-359.
56. Sandouk, T., D. Reda, and C. Hofmann. 1993. Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells. Am. J. Physiol. 264:C1600-C1608.
57. Scheinman, R. I., A. Gualberto, C. M. Jewell, J. A. Cidlowski, and A. S. Baldwin. 1995. Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors. Mol. Cell. Biol. 15:943-953.
58. Stein, B., and M. X. Yang. 1995. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBP beta. Mol. Cell. Biol. 15:4971-4979.
59. Stone, R. L., and D. A. Bernlohr. 1990. The molecular basis of inhibition of adipose conversion of murine 3T3-L1 cells by retinoic acid. Differentiation 45:119-127.
60. Tontonoz, P., E. Hu, J. Devine, E. G. Beale, and B. M. Spiegelman. 1995. PPARγ2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol. Cell. Biol. 15:351-357.
61. Tontonoz, P., E. Hu, R. A. Graves, A. I. Budavari, and B. M. Spiegelman. 1994. mPPARγ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8:1224-1234.
62. Tontonoz, P., E. Hu, and B. M. Spiegelman. 1994. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79:1147-1156.
63. Tsai, S., S. Bartelmez, R. Heyman, K. Damm, R. Evans, and S. J. Collins. 1992. A mutated retinoic acid receptor-alpha exhibiting dominant-negative activity alters the lineage development of a multipotent hematopoietic cell line. Genes Dev. 6:2258-2269.
64. Vasseur-Cognet, M., and M. D. Lane. 1993. CCAAT/enhanccr binding protein alpha (C/EBP alpha) undifferentiated protein: a developmentally regulated nuclear protein that binds to the C/EBP alpha gene promoter. Proc. Natl. Acad. Sci. USA 90:7312-7316.
65. Wang, N. D., M. J. Finegold, A. Bradley, C. N. Ou, S. V. Abdelsayed, M. D. Wilde, L. R. Taylor, D. R. Wilson, and G. J. Darlington. 1995. Impaired energy homeostasis in C/EBPα knockout mice. Science 269:1108-1112.
66. Williams, S. C., M. Baer, A. J. Dillner, and P. F. Johnson. 1995. CRP2 (C/EBP beta) contains a bipartite transcriptional activation, DNA binding and cell specificity. EMBO J. 14:3170-3183.
67. Wu, Z., N. L. R. Bucher, and S. R. Farmer. 1995. Conditional ectopic expression of C/EBPb in NIH-3T3 cells induces PPARγ and stimulates adipogenesis. Genes Dev. 9:2350-2363.
68. Wu, Z., N. L. R. Bucher, and S. R. Farmer. 1996. Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPβ, C/EBPδ, and glucocorticoids. Mol. Cell. Biol. 16:4128-4136.
69. Xue, J.-C., E. J. Schwarz, A. Chawla, and M. A. Lazar. 1996. Distinct stages in adipogenesis revealed by retinoid inhibition of differentiation after induction ot PPARγ. Mol. Cell. Biol. 16:1567-1575.
70. Yeh, W.-C., Z. Cao, M. Classon, and S. L. McKnight. 1995. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev. 9:168-181.
71. Yu K., W. Bayona, C. B. Kallen, H. P. Harding, C. Ravera, J. McMahon, M. Brown, and M. A. Lazar. 1995. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J. Biol. Chem. 270:23975-23983.
72. Yu, V. C., C. Delsert, B. Anderson, J. M. Holloway, O. V. Devary, A. M. Naar, S. Y. Kim, J.-M. Boulin, C. K. Glass, and M. G. Rosenfeld. 1991. RXRβ: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell. 67:1251-1266.
73. Zhu, Y., C. Qi, J. R. Korenberg, X.-N. Chen, D. Noya, M. S. Rao, and J. K. Reddy. 1995. Structural organization of mouse peroxisome proliferator-activated receptor γ (mPPARγ) gene: Alternative promoter use and different splicing yield two mPPARγ isoforms. Proc. Natl. Acad. Sci. USA 92:7921-7925.